Biodel Report issue

For profit Phase 1 Phase 3
Founded: Danbury CT United States (2003)
Status: Acquired by Albireo (2016)

Organization Overview

First Clinical Trial
2006
NCT01000922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree